Butterfly Network sees Q4 revenue growth of at least 17% year-over-year

Butterfly Network (BFLY) yesterday announced that it expects to report revenue growth for the fourth quarter ended December 31, 2025 of at least 17% year over year. Joseph DeVivo, Butterfly’s President, Chief Executive Officer and Chairman commented, “We enter 2026 with strong momentum and continued growth in our handheld ultrasound business. That foundation gives us confidence as we continue to scale our core commercial business, while evolving Butterfly as a differentiated Ultrasound-on-Chip and semiconductor company. As we expand co-development and chip licensing opportunities, 2026 represents a meaningful inflection year for the company – one I’ll begin to outline at the J.P. Morgan conference later this week.” John Doherty, Butterfly’s Chief Financial Officer added, “We expect to report audited fourth quarter and full year 2025 results in late February and to provide 2026 guidance at that time. Entering 2026, we are well positioned to deliver continued strong revenue growth together with a focus on disciplined financial management.” As previously announced, Butterfly will participate at the 44th Annual J.P. Morgan Healthcare Conference and will present on Thursday, January 15, 2026, at 9:00 AM PST.